| Trial ID: | L0855 |
| Source ID: | NCT02654665
|
| Associated Drug: |
Liraglutide
|
| Title: |
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
|
| Acronym: |
CGH-LiNASH
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease (NAFLD);Weight Loss;Non-alcoholic Steatohepatitis (NASH)
|
| Interventions: |
Behavioral: Lifestyle modification;Drug: Liraglutide
|
| Outcome Measures: |
Improvement in NASHnan
|
| Sponsor/Collaborators: |
Changi General Hospital
|
| Gender: |
All
|
| Age: |
21 Years65 Years
|
| Phases: |
Phase 3
|
| Enrollment: |
36
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
11/01/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Singapore
|
| URL: |
https://clinicaltrials.gov/show/NCT02654665
|
